Shuhei Sakai

机构：Kyoto Pharmaceutical University

发表论文 5 篇 · 总被引 22 次 · h-index 3

代表论文

• Assessment of pharmacokinetic variations of capecitabine after multiple administration in rats: a physiologically based pharmacokinetic model (2020 · Cancer Chemotherapy and Pharmacology · 被引 11)
• A Physiologically Based Pharmacokinetic–Pharmacodynamic Model for Capecitabine in Colorectal Cancer Rats: Simulation of Antitumor Efficacy at Various Administration Schedules (2021 · European Journal of Drug Metabolism and Pharmacokinetics · 被引 6)
• Assessment of Drug–drug Interaction and Optimization in Capecitabine and Irinotecan Combination Regimen using a Physiologically Based Pharmacokinetic Model (2021 · Journal of Pharmaceutical Sciences · 被引 5)
• Population Pharmacokinetic-pharmacodynamic Model Analysis of Dapagliflozin for HbA1c-lowering Effects in Japanese Patients with Type 2 Diabetes Mellitus using Long-term Real-world Data (2025 · International Journal of Medical Sciences)
• Effects of metabolic enzymes on the pharmacokinetics and pharmacodynamics of capecitabine in colorectal cancer rats (2019 · 日本癌学会学術総会抄録集(Web))